Multiple sclerosis in a patient with cryopyrin-associated autoinflammatory syndrome: Evidence that autoinflammation is the common link. 2021

Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
First Department of Internal Medicine, University Hospital of Alexandroupolis, Democritus University of Thrace, Alexandroupolis, Greece; Laboratory of Molecular Hematology, Democritus University of Thrace, Alexandroupolis, Greece.

The co-existence of an autoinflammatory syndrome with a demyelinating disorder is a very rare occurrence raising the question whether there is a pathophysiological connection between them. We describe the case of a man with symptoms of cryopyrin-associated periodic syndrome (CAPS) since infancy who later developed multiple sclerosis (MS). As CAPS was genetically confirmed, the inhibition of interleukin-1 (IL-1) with anakinra led to a swift resolution of the CAPS symptoms and also, in combination with teriflunomide, to a clinical and imaging improvement of MS. In vitro studies showed that, upon a CAPS flare, the patient's peripheral neutrophils released neutrophil extracellular traps (NETs) decorated with IL-1β, while NET release was markedly decreased following anakinra-induced remission of CAPS. Taking into account the growing evidence on the involvement of IL-1β in experimental models of MS, this rare patient case suggests that the role of neutrophils/NETs and IL-1β in MS should be further studied.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008279 Magnetic Resonance Imaging Non-invasive method of demonstrating internal anatomy based on the principle that atomic nuclei in a strong magnetic field absorb pulses of radiofrequency energy and emit them as radiowaves which can be reconstructed into computerized images. The concept includes proton spin tomographic techniques. Chemical Shift Imaging,MR Tomography,MRI Scans,MRI, Functional,Magnetic Resonance Image,Magnetic Resonance Imaging, Functional,Magnetization Transfer Contrast Imaging,NMR Imaging,NMR Tomography,Tomography, NMR,Tomography, Proton Spin,fMRI,Functional Magnetic Resonance Imaging,Imaging, Chemical Shift,Proton Spin Tomography,Spin Echo Imaging,Steady-State Free Precession MRI,Tomography, MR,Zeugmatography,Chemical Shift Imagings,Echo Imaging, Spin,Echo Imagings, Spin,Functional MRI,Functional MRIs,Image, Magnetic Resonance,Imaging, Magnetic Resonance,Imaging, NMR,Imaging, Spin Echo,Imagings, Chemical Shift,Imagings, Spin Echo,MRI Scan,MRIs, Functional,Magnetic Resonance Images,Resonance Image, Magnetic,Scan, MRI,Scans, MRI,Shift Imaging, Chemical,Shift Imagings, Chemical,Spin Echo Imagings,Steady State Free Precession MRI
D008297 Male Males
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D009570 Nitriles Organic compounds containing the -CN radical. The concept is distinguished from CYANIDES, which denotes inorganic salts of HYDROGEN CYANIDE. Nitrile
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003437 Crotonates Derivatives of BUTYRIC ACID that include a double bond between carbon 2 and 3 of the aliphatic structure. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the aminobutryrate structure. 2-Butenoic Acids,Crotonic Acids,2 Butenoic Acids,Acids, 2-Butenoic,Acids, Crotonic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006885 Hydroxybutyrates Salts and esters of hydroxybutyric acid. Hydroxybutyric Acid Derivatives,Hydroxybutyric Acids,Acid Derivatives, Hydroxybutyric

Related Publications

Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
June 2007, Annals of the rheumatic diseases,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
October 2023, La Revue du praticien,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
January 2016, Neurology,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
September 2014, Nature reviews. Rheumatology,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
July 2023, Allergology international : official journal of the Japanese Society of Allergology,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
July 2017, Annals of the rheumatic diseases,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
January 2011, Open access rheumatology : research and reviews,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
September 2019, International immunology,
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
December 2021, Life (Basel, Switzerland),
Charalampos Papagoras, and Vasiliki Lampropoulou, and Eleni Mavraki, and Akrivi Chrysanthopoulou, and Savas Deftereos, and Juan I Aróstegui, and Panagiotis Skendros, and Konstantinos Ritis
January 2013, Clinical ophthalmology (Auckland, N.Z.),
Copied contents to your clipboard!